Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03321604 · ClinicalTrials.gov registry record

Kidney Information Network for Disease Research and Education

A clinical trial, sponsored by Massachusetts General Hospital.

Terminated
Registry status
338
Enrollment target

NCT03321604: Clinical Trial study, sponsored by Massachusetts General Hospital.

NCT03321604 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 338 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03321604 was terminated before completion, sponsored by Massachusetts General Hospital.

TERMINATED
Registry status
338 participants
Enrollment target

Study Summary

In this study, Investigators will conduct a prospective cohort study of dialysis patients by collecting research-quality information on patient characteristics, comorbid diseases and laboratory markers used in routine practice, as well as novel biochemical markers and genetic data. Investigators will utilize data from the cohort to test the independent relationship between biochemical and genetic markers and Fabry disease and other rare diseases.

Trial Details

FieldValue
Enrollment Target 338 participants
Start Date 2018-01-01
Est. Completion 2019-11-21

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT03321604

The ClinicalTrials.gov registry entry for NCT03321604 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03321604 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03321604 about?

NCT03321604 is a clinical study titled "Kidney Information Network for Disease Research and Education". In this study, Investigators will conduct a prospective cohort study of dialysis patients by collecting research-quality information on patient characteristics, comorbid diseases and laboratory markers used in routine practice, as well as novel biochemical markers and genetic data. Investigators wil...

What is the current status of trial NCT03321604?

This trial is currently terminated. The enrollment target is 338 participants. The study started on 2018-01-01. Estimated completion is 2019-11-21.

Who is sponsoring clinical trial NCT03321604?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.